Global Orphan Drugs Market Research Report 2022 Professional Edition
The global Orphan Drugs market was valued at 10888.05 Million USD in 2021 and will grow with a CAGR of 9.56% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
By Types:
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
By Applications:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
By Types:
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
By Applications:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.5 Market by Application
1.5.1 Global Orphan Drugs Market Share by Application: 2022-2027
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Orphan Drugs Market
1.8.1 Global Orphan Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Orphan Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Orphan Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Orphan Drugs Production Sites, Area Served, Product Type
3 SALES BY REGION
3.1 Global Orphan Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Orphan Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Orphan Drugs Sales Volume
3.3.1 North America Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Orphan Drugs Sales Volume
3.4.1 East Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Orphan Drugs Sales Volume (2016-2021)
3.5.1 Europe Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Orphan Drugs Sales Volume (2016-2021)
3.6.1 South Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Orphan Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Orphan Drugs Sales Volume (2016-2021)
3.8.1 Middle East Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Orphan Drugs Sales Volume (2016-2021)
3.9.1 Africa Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Orphan Drugs Sales Volume (2016-2021)
3.10.1 Oceania Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Orphan Drugs Sales Volume (2016-2021)
3.11.1 South America Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Orphan Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 NORTH AMERICA
4.1 North America Orphan Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 EAST ASIA
5.1 East Asia Orphan Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 EUROPE
6.1 Europe Orphan Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 SOUTH ASIA
7.1 South Asia Orphan Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 SOUTHEAST ASIA
8.1 Southeast Asia Orphan Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 MIDDLE EAST
9.1 Middle East Orphan Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 AFRICA
10.1 Africa Orphan Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 OCEANIA
11.1 Oceania Orphan Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 SOUTH AMERICA
12.1 South America Orphan Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 REST OF THE WORLD
13.1 Rest of the World Orphan Drugs Consumption by Countries
13.2 Kazakhstan
14 SALES VOLUME, SALES REVENUE, SALES PRICE TREND BY TYPE
14.1 Global Orphan Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Orphan Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Orphan Drugs Sales Price by Type (2016-2021)
15 CONSUMPTION ANALYSIS BY APPLICATION
15.1 Global Orphan Drugs Consumption Volume by Application (2016-2021)
15.2 Global Orphan Drugs Consumption Value by Application (2016-2021)
16 COMPANY PROFILES AND KEY FIGURES IN ORPHAN DRUGS BUSINESS
16.1 Novartis AG
16.1.1 Novartis AG Company Profile
16.1.2 Novartis AG Orphan Drugs Product Specification
16.1.3 Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bristol-Myers Squibb Company
16.2.1 Bristol-Myers Squibb Company Company Profile
16.2.2 Bristol-Myers Squibb Company Orphan Drugs Product Specification
16.2.3 Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Celgene Corporation
16.3.1 Celgene Corporation Company Profile
16.3.2 Celgene Corporation Orphan Drugs Product Specification
16.3.3 Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 F. Hoffmann-La Roche Ltd.
16.4.1 F. Hoffmann-La Roche Ltd. Company Profile
16.4.2 F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
16.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Pfizer, Inc.
16.5.1 Pfizer, Inc. Company Profile
16.5.2 Pfizer, Inc. Orphan Drugs Product Specification
16.5.3 Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Sanofi S.A.
16.6.1 Sanofi S.A. Company Profile
16.6.2 Sanofi S.A. Orphan Drugs Product Specification
16.6.3 Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Alexion Pharmaceuticals, Inc.
16.7.1 Alexion Pharmaceuticals, Inc. Company Profile
16.7.2 Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
16.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Eli Lilly and Company
16.8.1 Eli Lilly and Company Company Profile
16.8.2 Eli Lilly and Company Orphan Drugs Product Specification
16.8.3 Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Novo Nordisk A/S
16.9.1 Novo Nordisk A/S Company Profile
16.9.2 Novo Nordisk A/S Orphan Drugs Product Specification
16.9.3 Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 AstraZeneca
16.10.1 AstraZeneca Company Profile
16.10.2 AstraZeneca Orphan Drugs Product Specification
16.10.3 AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Eisai Co., Ltd.
16.11.1 Eisai Co., Ltd. Company Profile
16.11.2 Eisai Co., Ltd. Orphan Drugs Product Specification
16.11.3 Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Daiichi Sankyo Company Limited
16.12.1 Daiichi Sankyo Company Limited Company Profile
16.12.2 Daiichi Sankyo Company Limited Orphan Drugs Product Specification
16.12.3 Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Bayer AG
16.13.1 Bayer AG Company Profile
16.13.2 Bayer AG Orphan Drugs Product Specification
16.13.3 Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 GlaxoSmithKline
16.14.1 GlaxoSmithKline Company Profile
16.14.2 GlaxoSmithKline Orphan Drugs Product Specification
16.14.3 GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Merck & Co., Inc.
16.15.1 Merck & Co., Inc. Company Profile
16.15.2 Merck & Co., Inc. Orphan Drugs Product Specification
16.15.3 Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Johnson & Johnson
16.16.1 Johnson & Johnson Company Profile
16.16.2 Johnson & Johnson Orphan Drugs Product Specification
16.16.3 Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Biogen, Inc.
16.17.1 Biogen, Inc. Company Profile
16.17.2 Biogen, Inc. Orphan Drugs Product Specification
16.17.3 Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Takeda
16.18.1 Takeda Company Profile
16.18.2 Takeda Orphan Drugs Product Specification
16.18.3 Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Amgen, Inc.
16.19.1 Amgen, Inc. Company Profile
16.19.2 Amgen, Inc. Orphan Drugs Product Specification
16.19.3 Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 ORPHAN DRUGS MANUFACTURING COST ANALYSIS
17.1 Orphan Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Orphan Drugs
17.4 Orphan Drugs Industrial Chain Analysis
18 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
18.1 Marketing Channel
18.2 Orphan Drugs Distributors List
18.3 Orphan Drugs Customers
19 MARKET DYNAMICS
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 PRODUCTION AND SUPPLY FORECAST
20.1 Global Forecasted Production of Orphan Drugs (2022-2027)
20.2 Global Forecasted Revenue of Orphan Drugs (2022-2027)
20.3 Global Forecasted Price of Orphan Drugs (2016-2027)
20.4 Global Forecasted Production of Orphan Drugs by Region (2022-2027)
20.4.1 North America Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Orphan Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Orphan Drugs by Application (2022-2027)
21 CONSUMPTION AND DEMAND FORECAST
21.1 North America Forecasted Consumption of Orphan Drugs by Country
21.2 East Asia Market Forecasted Consumption of Orphan Drugs by Country
21.3 Europe Market Forecasted Consumption of Orphan Drugs by Countriy
21.4 South Asia Forecasted Consumption of Orphan Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Orphan Drugs by Country
21.6 Middle East Forecasted Consumption of Orphan Drugs by Country
21.7 Africa Forecasted Consumption of Orphan Drugs by Country
21.8 Oceania Forecasted Consumption of Orphan Drugs by Country
21.9 South America Forecasted Consumption of Orphan Drugs by Country
21.10 Rest of the world Forecasted Consumption of Orphan Drugs by Country
22 RESEARCH FINDINGS AND CONCLUSION
23 METHODOLOGY AND DATA SOURCE
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.5 Market by Application
1.5.1 Global Orphan Drugs Market Share by Application: 2022-2027
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Orphan Drugs Market
1.8.1 Global Orphan Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Orphan Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Orphan Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Orphan Drugs Production Sites, Area Served, Product Type
3 SALES BY REGION
3.1 Global Orphan Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global Orphan Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America Orphan Drugs Sales Volume
3.3.1 North America Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Orphan Drugs Sales Volume
3.4.1 East Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Orphan Drugs Sales Volume (2016-2021)
3.5.1 Europe Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Orphan Drugs Sales Volume (2016-2021)
3.6.1 South Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Orphan Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Orphan Drugs Sales Volume (2016-2021)
3.8.1 Middle East Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Orphan Drugs Sales Volume (2016-2021)
3.9.1 Africa Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Orphan Drugs Sales Volume (2016-2021)
3.10.1 Oceania Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Orphan Drugs Sales Volume (2016-2021)
3.11.1 South America Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Orphan Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World Orphan Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 NORTH AMERICA
4.1 North America Orphan Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 EAST ASIA
5.1 East Asia Orphan Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 EUROPE
6.1 Europe Orphan Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 SOUTH ASIA
7.1 South Asia Orphan Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 SOUTHEAST ASIA
8.1 Southeast Asia Orphan Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 MIDDLE EAST
9.1 Middle East Orphan Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 AFRICA
10.1 Africa Orphan Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 OCEANIA
11.1 Oceania Orphan Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 SOUTH AMERICA
12.1 South America Orphan Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 REST OF THE WORLD
13.1 Rest of the World Orphan Drugs Consumption by Countries
13.2 Kazakhstan
14 SALES VOLUME, SALES REVENUE, SALES PRICE TREND BY TYPE
14.1 Global Orphan Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global Orphan Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global Orphan Drugs Sales Price by Type (2016-2021)
15 CONSUMPTION ANALYSIS BY APPLICATION
15.1 Global Orphan Drugs Consumption Volume by Application (2016-2021)
15.2 Global Orphan Drugs Consumption Value by Application (2016-2021)
16 COMPANY PROFILES AND KEY FIGURES IN ORPHAN DRUGS BUSINESS
16.1 Novartis AG
16.1.1 Novartis AG Company Profile
16.1.2 Novartis AG Orphan Drugs Product Specification
16.1.3 Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bristol-Myers Squibb Company
16.2.1 Bristol-Myers Squibb Company Company Profile
16.2.2 Bristol-Myers Squibb Company Orphan Drugs Product Specification
16.2.3 Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Celgene Corporation
16.3.1 Celgene Corporation Company Profile
16.3.2 Celgene Corporation Orphan Drugs Product Specification
16.3.3 Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 F. Hoffmann-La Roche Ltd.
16.4.1 F. Hoffmann-La Roche Ltd. Company Profile
16.4.2 F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
16.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Pfizer, Inc.
16.5.1 Pfizer, Inc. Company Profile
16.5.2 Pfizer, Inc. Orphan Drugs Product Specification
16.5.3 Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Sanofi S.A.
16.6.1 Sanofi S.A. Company Profile
16.6.2 Sanofi S.A. Orphan Drugs Product Specification
16.6.3 Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Alexion Pharmaceuticals, Inc.
16.7.1 Alexion Pharmaceuticals, Inc. Company Profile
16.7.2 Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
16.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Eli Lilly and Company
16.8.1 Eli Lilly and Company Company Profile
16.8.2 Eli Lilly and Company Orphan Drugs Product Specification
16.8.3 Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Novo Nordisk A/S
16.9.1 Novo Nordisk A/S Company Profile
16.9.2 Novo Nordisk A/S Orphan Drugs Product Specification
16.9.3 Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 AstraZeneca
16.10.1 AstraZeneca Company Profile
16.10.2 AstraZeneca Orphan Drugs Product Specification
16.10.3 AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Eisai Co., Ltd.
16.11.1 Eisai Co., Ltd. Company Profile
16.11.2 Eisai Co., Ltd. Orphan Drugs Product Specification
16.11.3 Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Daiichi Sankyo Company Limited
16.12.1 Daiichi Sankyo Company Limited Company Profile
16.12.2 Daiichi Sankyo Company Limited Orphan Drugs Product Specification
16.12.3 Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Bayer AG
16.13.1 Bayer AG Company Profile
16.13.2 Bayer AG Orphan Drugs Product Specification
16.13.3 Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 GlaxoSmithKline
16.14.1 GlaxoSmithKline Company Profile
16.14.2 GlaxoSmithKline Orphan Drugs Product Specification
16.14.3 GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Merck & Co., Inc.
16.15.1 Merck & Co., Inc. Company Profile
16.15.2 Merck & Co., Inc. Orphan Drugs Product Specification
16.15.3 Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Johnson & Johnson
16.16.1 Johnson & Johnson Company Profile
16.16.2 Johnson & Johnson Orphan Drugs Product Specification
16.16.3 Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Biogen, Inc.
16.17.1 Biogen, Inc. Company Profile
16.17.2 Biogen, Inc. Orphan Drugs Product Specification
16.17.3 Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Takeda
16.18.1 Takeda Company Profile
16.18.2 Takeda Orphan Drugs Product Specification
16.18.3 Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Amgen, Inc.
16.19.1 Amgen, Inc. Company Profile
16.19.2 Amgen, Inc. Orphan Drugs Product Specification
16.19.3 Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 ORPHAN DRUGS MANUFACTURING COST ANALYSIS
17.1 Orphan Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Orphan Drugs
17.4 Orphan Drugs Industrial Chain Analysis
18 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
18.1 Marketing Channel
18.2 Orphan Drugs Distributors List
18.3 Orphan Drugs Customers
19 MARKET DYNAMICS
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 PRODUCTION AND SUPPLY FORECAST
20.1 Global Forecasted Production of Orphan Drugs (2022-2027)
20.2 Global Forecasted Revenue of Orphan Drugs (2022-2027)
20.3 Global Forecasted Price of Orphan Drugs (2016-2027)
20.4 Global Forecasted Production of Orphan Drugs by Region (2022-2027)
20.4.1 North America Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America Orphan Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Orphan Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Orphan Drugs by Application (2022-2027)
21 CONSUMPTION AND DEMAND FORECAST
21.1 North America Forecasted Consumption of Orphan Drugs by Country
21.2 East Asia Market Forecasted Consumption of Orphan Drugs by Country
21.3 Europe Market Forecasted Consumption of Orphan Drugs by Countriy
21.4 South Asia Forecasted Consumption of Orphan Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Orphan Drugs by Country
21.6 Middle East Forecasted Consumption of Orphan Drugs by Country
21.7 Africa Forecasted Consumption of Orphan Drugs by Country
21.8 Oceania Forecasted Consumption of Orphan Drugs by Country
21.9 South America Forecasted Consumption of Orphan Drugs by Country
21.10 Rest of the world Forecasted Consumption of Orphan Drugs by Country
22 RESEARCH FINDINGS AND CONCLUSION
23 METHODOLOGY AND DATA SOURCE
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
LIST OF TABLES AND FIGURES
Key Players Covered: Ranking by Orphan Drugs Revenue (US$ Million) 2016-2021
Global Orphan Drugs Market Size by Type (US$ Million): 2022-2027
Global Orphan Drugs Market Size by Application (US$ Million): 2022-2027
Global Orphan Drugs Production Capacity by Manufacturers
Global Orphan Drugs Production by Manufacturers (2016-2021)
Global Orphan Drugs Production Market Share by Manufacturers (2016-2021)
Global Orphan Drugs Revenue by Manufacturers (2016-2021)
Global Orphan Drugs Revenue Share by Manufacturers (2016-2021)
Global Market Orphan Drugs Average Price of Key Manufacturers (2016-2021)
Manufacturers Orphan Drugs Production Sites and Area Served
Manufacturers Orphan Drugs Product Type
Global Orphan Drugs Sales Volume by Region (2016-2021)
Global Orphan Drugs Sales Volume Market Share by Region (2016-2021)
Global Orphan Drugs Sales Revenue by Region (2016-2021)
Global Orphan Drugs Sales Revenue Market Share by Region (2016-2021)
North America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Orphan Drugs Consumption by Countries (2016-2021)
East Asia Orphan Drugs Consumption by Countries (2016-2021)
Europe Orphan Drugs Consumption by Region (2016-2021)
South Asia Orphan Drugs Consumption by Countries (2016-2021)
Southeast Asia Orphan Drugs Consumption by Countries (2016-2021)
Middle East Orphan Drugs Consumption by Countries (2016-2021)
Africa Orphan Drugs Consumption by Countries (2016-2021)
Oceania Orphan Drugs Consumption by Countries (2016-2021)
South America Orphan Drugs Consumption by Countries (2016-2021)
Rest of the World Orphan Drugs Consumption by Countries (2016-2021)
Global Orphan Drugs Sales Volume by Type (2016-2021)
Global Orphan Drugs Sales Volume Market Share by Type (2016-2021)
Global Orphan Drugs Sales Revenue by Type (2016-2021)
Global Orphan Drugs Sales Revenue Share by Type (2016-2021)
Global Orphan Drugs Sales Price by Type (2016-2021)
Global Orphan Drugs Consumption Volume by Application (2016-2021)
Global Orphan Drugs Consumption Volume Market Share by Application (2016-2021)
Global Orphan Drugs Consumption Value by Application (2016-2021)
Global Orphan Drugs Consumption Value Market Share by Application (2016-2021)
Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Orphan Drugs Distributors List
Orphan Drugs Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Orphan Drugs Production Forecast by Region (2022-2027)
Global Orphan Drugs Sales Volume Forecast by Type (2022-2027)
Global Orphan Drugs Sales Volume Market Share Forecast by Type (2022-2027)
Global Orphan Drugs Sales Revenue Forecast by Type (2022-2027)
Global Orphan Drugs Sales Revenue Market Share Forecast by Type (2022-2027)
Global Orphan Drugs Sales Price Forecast by Type (2022-2027)
Global Orphan Drugs Consumption Volume Forecast by Application (2022-2027)
Global Orphan Drugs Consumption Value Forecast by Application (2022-2027)
North America Orphan Drugs Consumption Forecast 2022-2027 by Country
East Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Europe Orphan Drugs Consumption Forecast 2022-2027 by Country
South Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Southeast Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Middle East Orphan Drugs Consumption Forecast 2022-2027 by Country
Africa Orphan Drugs Consumption Forecast 2022-2027 by Country
Oceania Orphan Drugs Consumption Forecast 2022-2027 by Country
South America Orphan Drugs Consumption Forecast 2022-2027 by Country
Rest of the world Orphan Drugs Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Orphan Drugs Market Share by Type: 2021 VS 2027
Oncology Features
Gastrointestinal Features
Pulmonary Features
Neurology Features
Hematology Features
Cardio-vascular Features
Metabolic disorders Features
Endocrinology Features
Infectious diseases Features
Global Orphan Drugs Market Share by Application: 2021 VS 2027
Hospital Pharmacies Case Studies
Speciality Pharmacies Case Studies
Retail pharmacies Case Studies
Orphan Drugs Report Years Considered
Global Orphan Drugs Market Status and Outlook (2016-2027)
North America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
East Asia Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Europe Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South Asia Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Middle East Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Africa Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Oceania Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
North America Orphan Drugs Sales Volume Growth Rate (2016-2021)
East Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Europe Orphan Drugs Sales Volume Growth Rate (2016-2021)
South Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Southeast Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Middle East Orphan Drugs Sales Volume Growth Rate (2016-2021)
Africa Orphan Drugs Sales Volume Growth Rate (2016-2021)
Oceania Orphan Drugs Sales Volume Growth Rate (2016-2021)
South America Orphan Drugs Sales Volume Growth Rate (2016-2021)
Rest of the World Orphan Drugs Sales Volume Growth Rate (2016-2021)
North America Orphan Drugs Consumption and Growth Rate (2016-2021)
North America Orphan Drugs Consumption Market Share by Countries in 2021
United States Orphan Drugs Consumption and Growth Rate (2016-2021)
Canada Orphan Drugs Consumption and Growth Rate (2016-2021)
Mexico Orphan Drugs Consumption and Growth Rate (2016-2021)
East Asia Orphan Drugs Consumption and Growth Rate (2016-2021)
East Asia Orphan Drugs Consumption Market Share by Countries in 2021
China Orphan Drugs Consumption and Growth Rate (2016-2021)
Japan Orphan Drugs Consumption and Growth Rate (2016-2021)
South Korea Orphan Drugs Consumption and Growth Rate (2016-2021)
Europe Orphan Drugs Consumption and Growth Rate
Europe Orphan Drugs Consumption Market Share by Region in 2021
Germany Orphan Drugs Consumption and Growth Rate (2016-2021)
United Kingdom Orphan Drugs Consumption and Growth Rate (2016-2021)
France Orphan Drugs Consumption and Growth Rate (2016-2021)
Italy Orphan Drugs Consumption and Growth Rate (2016-2021)
Russia Orphan Drugs Consumption and Growth Rate (2016-2021)
Spain Orphan Drugs Consumption and Growth Rate (2016-2021)
Netherlands Orphan Drugs Consumption and Growth Rate (2016-2021)
Switzerland Orphan Drugs Consumption and Growth Rate (2016-2021)
Poland Orphan Drugs Consumption and Growth Rate (2016-2021)
South Asia Orphan Drugs Consumption and Growth Rate
South Asia Orphan Drugs Consumption Market Share by Countries in 2021
India Orphan Drugs Consumption and Growth Rate (2016-2021)
Pakistan Orphan Drugs Consumption and Growth Rate (2016-2021)
Bangladesh Orphan Drugs Consumption and Growth Rate (2016-2021)
Southeast Asia Orphan Drugs Consumption and Growth Rate
Southeast Asia Orphan Drugs Consumption Market Share by Countries in 2021
Indonesia Orphan Drugs Consumption and Growth Rate (2016-2021)
Thailand Orphan Drugs Consumption and Growth Rate (2016-2021)
Singapore Orphan Drugs Consumption and Growth Rate (2016-2021)
Malaysia Orphan Drugs Consumption and Growth Rate (2016-2021)
Philippines Orphan Drugs Consumption and Growth Rate (2016-2021)
Vietnam Orphan Drugs Consumption and Growth Rate (2016-2021)
Myanmar Orphan Drugs Consumption and Growth Rate (2016-2021)
Middle East Orphan Drugs Consumption and Growth Rate
Middle East Orphan Drugs Consumption Market Share by Countries in 2021
Turkey Orphan Drugs Consumption and Growth Rate (2016-2021)
Saudi Arabia Orphan Drugs Consumption and Growth Rate (2016-2021)
Iran Orphan Drugs Consumption and Growth Rate (2016-2021)
United Arab Emirates Orphan Drugs Consumption and Growth Rate (2016-2021)
Israel Orphan Drugs Consumption and Growth Rate (2016-2021)
Iraq Orphan Drugs Consumption and Growth Rate (2016-2021)
Qatar Orphan Drugs Consumption and Growth Rate (2016-2021)
Kuwait Orphan Drugs Consumption and Growth Rate (2016-2021)
Oman Orphan Drugs Consumption and Growth Rate (2016-2021)
Africa Orphan Drugs Consumption and Growth Rate
Africa Orphan Drugs Consumption Market Share by Countries in 2021
Nigeria Orphan Drugs Consumption and Growth Rate (2016-2021)
South Africa Orphan Drugs Consumption and Growth Rate (2016-2021)
Egypt Orphan Drugs Consumption and Growth Rate (2016-2021)
Algeria Orphan Drugs Consumption and Growth Rate (2016-2021)
Morocco Orphan Drugs Consumption and Growth Rate (2016-2021)
Oceania Orphan Drugs Consumption and Growth Rate
Oceania Orphan Drugs Consumption Market Share by Countries in 2021
Australia Orphan Drugs Consumption and Growth Rate (2016-2021)
New Zealand Orphan Drugs Consumption and Growth Rate (2016-2021)
South America Orphan Drugs Consumption and Growth Rate
South America Orphan Drugs Consumption Market Share by Countries in 2021
Brazil Orphan Drugs Consumption and Growth Rate (2016-2021)
Argentina Orphan Drugs Consumption and Growth Rate (2016-2021)
Columbia Orphan Drugs Consumption and Growth Rate (2016-2021)
Chile Orphan Drugs Consumption and Growth Rate (2016-2021)
Venezuelal Orphan Drugs Consumption and Growth Rate (2016-2021)
Peru Orphan Drugs Consumption and Growth Rate (2016-2021)
Puerto Rico Orphan Drugs Consumption and Growth Rate (2016-2021)
Ecuador Orphan Drugs Consumption and Growth Rate (2016-2021)
Rest of the World Orphan Drugs Consumption and Growth Rate
Rest of the World Orphan Drugs Consumption Market Share by Countries in 2021
Kazakhstan Orphan Drugs Consumption and Growth Rate (2016-2021)
Sales Market Share of Orphan Drugs by Type in 2021
Sales Revenue Market Share of Orphan Drugs by Type in 2021
Global Orphan Drugs Consumption Volume Market Share by Application in 2021
Novartis AG Orphan Drugs Product Specification
Bristol-Myers Squibb Company Orphan Drugs Product Specification
Celgene Corporation Orphan Drugs Product Specification
F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
Pfizer, Inc. Orphan Drugs Product Specification
Sanofi S.A. Orphan Drugs Product Specification
Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
Eli Lilly and Company Orphan Drugs Product Specification
Novo Nordisk A/S Orphan Drugs Product Specification
AstraZeneca Orphan Drugs Product Specification
Eisai Co., Ltd. Orphan Drugs Product Specification
Daiichi Sankyo Company Limited Orphan Drugs Product Specification
Bayer AG Orphan Drugs Product Specification
GlaxoSmithKline Orphan Drugs Product Specification
Merck & Co., Inc. Orphan Drugs Product Specification
Johnson & Johnson Orphan Drugs Product Specification
Biogen, Inc. Orphan Drugs Product Specification
Takeda Orphan Drugs Product Specification
Amgen, Inc. Orphan Drugs Product Specification
Manufacturing Cost Structure of Orphan Drugs
Manufacturing Process Analysis of Orphan Drugs
Orphan Drugs Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Orphan Drugs Production Capacity Growth Rate Forecast (2022-2027)
Global Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Global Orphan Drugs Price and Trend Forecast (2016-2027)
North America Orphan Drugs Production Growth Rate Forecast (2022-2027)
North America Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
East Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
East Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Europe Orphan Drugs Production Growth Rate Forecast (2022-2027)
Europe Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
South Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
South Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
Southeast Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Middle East Orphan Drugs Production Growth Rate Forecast (2022-2027)
Middle East Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Africa Orphan Drugs Production Growth Rate Forecast (2022-2027)
Africa Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Oceania Orphan Drugs Production Growth Rate Forecast (2022-2027)
Oceania Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
South America Orphan Drugs Production Growth Rate Forecast (2022-2027)
South America Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Rest of the World Orphan Drugs Production Growth Rate Forecast (2022-2027)
Rest of the World Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
North America Orphan Drugs Consumption Forecast 2022-2027
East Asia Orphan Drugs Consumption Forecast 2022-2027
Europe Orphan Drugs Consumption Forecast 2022-2027
South Asia Orphan Drugs Consumption Forecast 2022-2027
Southeast Asia Orphan Drugs Consumption Forecast 2022-2027
Middle East Orphan Drugs Consumption Forecast 2022-2027
Africa Orphan Drugs Consumption Forecast 2022-2027
Oceania Orphan Drugs Consumption Forecast 2022-2027
South America Orphan Drugs Consumption Forecast 2022-2027
Rest of the world Orphan Drugs Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
Key Players Covered: Ranking by Orphan Drugs Revenue (US$ Million) 2016-2021
Global Orphan Drugs Market Size by Type (US$ Million): 2022-2027
Global Orphan Drugs Market Size by Application (US$ Million): 2022-2027
Global Orphan Drugs Production Capacity by Manufacturers
Global Orphan Drugs Production by Manufacturers (2016-2021)
Global Orphan Drugs Production Market Share by Manufacturers (2016-2021)
Global Orphan Drugs Revenue by Manufacturers (2016-2021)
Global Orphan Drugs Revenue Share by Manufacturers (2016-2021)
Global Market Orphan Drugs Average Price of Key Manufacturers (2016-2021)
Manufacturers Orphan Drugs Production Sites and Area Served
Manufacturers Orphan Drugs Product Type
Global Orphan Drugs Sales Volume by Region (2016-2021)
Global Orphan Drugs Sales Volume Market Share by Region (2016-2021)
Global Orphan Drugs Sales Revenue by Region (2016-2021)
Global Orphan Drugs Sales Revenue Market Share by Region (2016-2021)
North America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Orphan Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Orphan Drugs Consumption by Countries (2016-2021)
East Asia Orphan Drugs Consumption by Countries (2016-2021)
Europe Orphan Drugs Consumption by Region (2016-2021)
South Asia Orphan Drugs Consumption by Countries (2016-2021)
Southeast Asia Orphan Drugs Consumption by Countries (2016-2021)
Middle East Orphan Drugs Consumption by Countries (2016-2021)
Africa Orphan Drugs Consumption by Countries (2016-2021)
Oceania Orphan Drugs Consumption by Countries (2016-2021)
South America Orphan Drugs Consumption by Countries (2016-2021)
Rest of the World Orphan Drugs Consumption by Countries (2016-2021)
Global Orphan Drugs Sales Volume by Type (2016-2021)
Global Orphan Drugs Sales Volume Market Share by Type (2016-2021)
Global Orphan Drugs Sales Revenue by Type (2016-2021)
Global Orphan Drugs Sales Revenue Share by Type (2016-2021)
Global Orphan Drugs Sales Price by Type (2016-2021)
Global Orphan Drugs Consumption Volume by Application (2016-2021)
Global Orphan Drugs Consumption Volume Market Share by Application (2016-2021)
Global Orphan Drugs Consumption Value by Application (2016-2021)
Global Orphan Drugs Consumption Value Market Share by Application (2016-2021)
Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Orphan Drugs Distributors List
Orphan Drugs Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Orphan Drugs Production Forecast by Region (2022-2027)
Global Orphan Drugs Sales Volume Forecast by Type (2022-2027)
Global Orphan Drugs Sales Volume Market Share Forecast by Type (2022-2027)
Global Orphan Drugs Sales Revenue Forecast by Type (2022-2027)
Global Orphan Drugs Sales Revenue Market Share Forecast by Type (2022-2027)
Global Orphan Drugs Sales Price Forecast by Type (2022-2027)
Global Orphan Drugs Consumption Volume Forecast by Application (2022-2027)
Global Orphan Drugs Consumption Value Forecast by Application (2022-2027)
North America Orphan Drugs Consumption Forecast 2022-2027 by Country
East Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Europe Orphan Drugs Consumption Forecast 2022-2027 by Country
South Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Southeast Asia Orphan Drugs Consumption Forecast 2022-2027 by Country
Middle East Orphan Drugs Consumption Forecast 2022-2027 by Country
Africa Orphan Drugs Consumption Forecast 2022-2027 by Country
Oceania Orphan Drugs Consumption Forecast 2022-2027 by Country
South America Orphan Drugs Consumption Forecast 2022-2027 by Country
Rest of the world Orphan Drugs Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Orphan Drugs Market Share by Type: 2021 VS 2027
Oncology Features
Gastrointestinal Features
Pulmonary Features
Neurology Features
Hematology Features
Cardio-vascular Features
Metabolic disorders Features
Endocrinology Features
Infectious diseases Features
Global Orphan Drugs Market Share by Application: 2021 VS 2027
Hospital Pharmacies Case Studies
Speciality Pharmacies Case Studies
Retail pharmacies Case Studies
Orphan Drugs Report Years Considered
Global Orphan Drugs Market Status and Outlook (2016-2027)
North America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
East Asia Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Europe Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South Asia Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Middle East Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Africa Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Oceania Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
South America Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Orphan Drugs Revenue (Value) and Growth Rate (2016-2027)
North America Orphan Drugs Sales Volume Growth Rate (2016-2021)
East Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Europe Orphan Drugs Sales Volume Growth Rate (2016-2021)
South Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Southeast Asia Orphan Drugs Sales Volume Growth Rate (2016-2021)
Middle East Orphan Drugs Sales Volume Growth Rate (2016-2021)
Africa Orphan Drugs Sales Volume Growth Rate (2016-2021)
Oceania Orphan Drugs Sales Volume Growth Rate (2016-2021)
South America Orphan Drugs Sales Volume Growth Rate (2016-2021)
Rest of the World Orphan Drugs Sales Volume Growth Rate (2016-2021)
North America Orphan Drugs Consumption and Growth Rate (2016-2021)
North America Orphan Drugs Consumption Market Share by Countries in 2021
United States Orphan Drugs Consumption and Growth Rate (2016-2021)
Canada Orphan Drugs Consumption and Growth Rate (2016-2021)
Mexico Orphan Drugs Consumption and Growth Rate (2016-2021)
East Asia Orphan Drugs Consumption and Growth Rate (2016-2021)
East Asia Orphan Drugs Consumption Market Share by Countries in 2021
China Orphan Drugs Consumption and Growth Rate (2016-2021)
Japan Orphan Drugs Consumption and Growth Rate (2016-2021)
South Korea Orphan Drugs Consumption and Growth Rate (2016-2021)
Europe Orphan Drugs Consumption and Growth Rate
Europe Orphan Drugs Consumption Market Share by Region in 2021
Germany Orphan Drugs Consumption and Growth Rate (2016-2021)
United Kingdom Orphan Drugs Consumption and Growth Rate (2016-2021)
France Orphan Drugs Consumption and Growth Rate (2016-2021)
Italy Orphan Drugs Consumption and Growth Rate (2016-2021)
Russia Orphan Drugs Consumption and Growth Rate (2016-2021)
Spain Orphan Drugs Consumption and Growth Rate (2016-2021)
Netherlands Orphan Drugs Consumption and Growth Rate (2016-2021)
Switzerland Orphan Drugs Consumption and Growth Rate (2016-2021)
Poland Orphan Drugs Consumption and Growth Rate (2016-2021)
South Asia Orphan Drugs Consumption and Growth Rate
South Asia Orphan Drugs Consumption Market Share by Countries in 2021
India Orphan Drugs Consumption and Growth Rate (2016-2021)
Pakistan Orphan Drugs Consumption and Growth Rate (2016-2021)
Bangladesh Orphan Drugs Consumption and Growth Rate (2016-2021)
Southeast Asia Orphan Drugs Consumption and Growth Rate
Southeast Asia Orphan Drugs Consumption Market Share by Countries in 2021
Indonesia Orphan Drugs Consumption and Growth Rate (2016-2021)
Thailand Orphan Drugs Consumption and Growth Rate (2016-2021)
Singapore Orphan Drugs Consumption and Growth Rate (2016-2021)
Malaysia Orphan Drugs Consumption and Growth Rate (2016-2021)
Philippines Orphan Drugs Consumption and Growth Rate (2016-2021)
Vietnam Orphan Drugs Consumption and Growth Rate (2016-2021)
Myanmar Orphan Drugs Consumption and Growth Rate (2016-2021)
Middle East Orphan Drugs Consumption and Growth Rate
Middle East Orphan Drugs Consumption Market Share by Countries in 2021
Turkey Orphan Drugs Consumption and Growth Rate (2016-2021)
Saudi Arabia Orphan Drugs Consumption and Growth Rate (2016-2021)
Iran Orphan Drugs Consumption and Growth Rate (2016-2021)
United Arab Emirates Orphan Drugs Consumption and Growth Rate (2016-2021)
Israel Orphan Drugs Consumption and Growth Rate (2016-2021)
Iraq Orphan Drugs Consumption and Growth Rate (2016-2021)
Qatar Orphan Drugs Consumption and Growth Rate (2016-2021)
Kuwait Orphan Drugs Consumption and Growth Rate (2016-2021)
Oman Orphan Drugs Consumption and Growth Rate (2016-2021)
Africa Orphan Drugs Consumption and Growth Rate
Africa Orphan Drugs Consumption Market Share by Countries in 2021
Nigeria Orphan Drugs Consumption and Growth Rate (2016-2021)
South Africa Orphan Drugs Consumption and Growth Rate (2016-2021)
Egypt Orphan Drugs Consumption and Growth Rate (2016-2021)
Algeria Orphan Drugs Consumption and Growth Rate (2016-2021)
Morocco Orphan Drugs Consumption and Growth Rate (2016-2021)
Oceania Orphan Drugs Consumption and Growth Rate
Oceania Orphan Drugs Consumption Market Share by Countries in 2021
Australia Orphan Drugs Consumption and Growth Rate (2016-2021)
New Zealand Orphan Drugs Consumption and Growth Rate (2016-2021)
South America Orphan Drugs Consumption and Growth Rate
South America Orphan Drugs Consumption Market Share by Countries in 2021
Brazil Orphan Drugs Consumption and Growth Rate (2016-2021)
Argentina Orphan Drugs Consumption and Growth Rate (2016-2021)
Columbia Orphan Drugs Consumption and Growth Rate (2016-2021)
Chile Orphan Drugs Consumption and Growth Rate (2016-2021)
Venezuelal Orphan Drugs Consumption and Growth Rate (2016-2021)
Peru Orphan Drugs Consumption and Growth Rate (2016-2021)
Puerto Rico Orphan Drugs Consumption and Growth Rate (2016-2021)
Ecuador Orphan Drugs Consumption and Growth Rate (2016-2021)
Rest of the World Orphan Drugs Consumption and Growth Rate
Rest of the World Orphan Drugs Consumption Market Share by Countries in 2021
Kazakhstan Orphan Drugs Consumption and Growth Rate (2016-2021)
Sales Market Share of Orphan Drugs by Type in 2021
Sales Revenue Market Share of Orphan Drugs by Type in 2021
Global Orphan Drugs Consumption Volume Market Share by Application in 2021
Novartis AG Orphan Drugs Product Specification
Bristol-Myers Squibb Company Orphan Drugs Product Specification
Celgene Corporation Orphan Drugs Product Specification
F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
Pfizer, Inc. Orphan Drugs Product Specification
Sanofi S.A. Orphan Drugs Product Specification
Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
Eli Lilly and Company Orphan Drugs Product Specification
Novo Nordisk A/S Orphan Drugs Product Specification
AstraZeneca Orphan Drugs Product Specification
Eisai Co., Ltd. Orphan Drugs Product Specification
Daiichi Sankyo Company Limited Orphan Drugs Product Specification
Bayer AG Orphan Drugs Product Specification
GlaxoSmithKline Orphan Drugs Product Specification
Merck & Co., Inc. Orphan Drugs Product Specification
Johnson & Johnson Orphan Drugs Product Specification
Biogen, Inc. Orphan Drugs Product Specification
Takeda Orphan Drugs Product Specification
Amgen, Inc. Orphan Drugs Product Specification
Manufacturing Cost Structure of Orphan Drugs
Manufacturing Process Analysis of Orphan Drugs
Orphan Drugs Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Orphan Drugs Production Capacity Growth Rate Forecast (2022-2027)
Global Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Global Orphan Drugs Price and Trend Forecast (2016-2027)
North America Orphan Drugs Production Growth Rate Forecast (2022-2027)
North America Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
East Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
East Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Europe Orphan Drugs Production Growth Rate Forecast (2022-2027)
Europe Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
South Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
South Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Orphan Drugs Production Growth Rate Forecast (2022-2027)
Southeast Asia Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Middle East Orphan Drugs Production Growth Rate Forecast (2022-2027)
Middle East Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Africa Orphan Drugs Production Growth Rate Forecast (2022-2027)
Africa Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Oceania Orphan Drugs Production Growth Rate Forecast (2022-2027)
Oceania Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
South America Orphan Drugs Production Growth Rate Forecast (2022-2027)
South America Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
Rest of the World Orphan Drugs Production Growth Rate Forecast (2022-2027)
Rest of the World Orphan Drugs Revenue Growth Rate Forecast (2022-2027)
North America Orphan Drugs Consumption Forecast 2022-2027
East Asia Orphan Drugs Consumption Forecast 2022-2027
Europe Orphan Drugs Consumption Forecast 2022-2027
South Asia Orphan Drugs Consumption Forecast 2022-2027
Southeast Asia Orphan Drugs Consumption Forecast 2022-2027
Middle East Orphan Drugs Consumption Forecast 2022-2027
Africa Orphan Drugs Consumption Forecast 2022-2027
Oceania Orphan Drugs Consumption Forecast 2022-2027
South America Orphan Drugs Consumption Forecast 2022-2027
Rest of the world Orphan Drugs Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
